Cassia abbreviata

Cassia abbreviata · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Cassia abbreviata is a botanical species characterized by a diverse chemical profile rich in bioactive polyphenols. Researchers have focused on various plant parts, including the leaf, stem, and root, to evaluate its pharmacological potential. Through the use of diverse preparations such as acetone extracts, HSHR, and both aqueous and organic fractions, the plant's therapeutic properties are being systematically explored. Scientific investigations are particularly interested in its effects on blood pressure and its interactions with the CYP1A2, CYP2C19, and CYP2C9 enzymes. These studies aim to provide a deeper understanding of how the plant's extracts may influence metabolic processes and cardiovascular health.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Fabaceae
Distribution
Not available
Plant Parts
Leaf · Stem

Classification

Common Names

Cassia abbreviata is a versatile botanical species known by a diverse array of regional and descriptive names. In various local contexts, it is frequently referred to as Hahanyama or Mulumanhyama. It also carries the common name Long-tail Cassia, which highlights its distinctive physical characteristics. Depending on the specific area or dialect, the plant may also be called Mchalamira or Muremberembe. These varied identities illustrate the deep cultural and linguistic connections surrounding this particular plant.

Sources: Catalogue of Life (COL)

Taxonomy

Cassia abbreviata belongs to the vast kingdom Plantae, representing the diverse world of living vegetation. Within this kingdom, the species is classified under the class Equisetopsida. It further descends through the order Fabales, which links it to a specific lineage of flowering plants. As a member of the genus Cassia, it shares close evolutionary ties with its botanical relatives. Finally, it is situated within the family Fabaceae, a group known for its distinctive and widespread botanical characteristics.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Fabales
Family Fabaceae
Genus Cassia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Cassia abbreviata is a notable plant species with a broad distribution spanning several regions across the African continent. Within East Tropical Africa, it can be found growing in the diverse landscapes of both Kenya and Tanzania. Its presence extends further into Northeast Tropical Africa, specifically within the borders of Somalia. The species also inhabits parts of South Tropical Africa, including the nations of Malawi and Mozambique. This wide geographical range highlights the plant's ability to adapt to various tropical environments.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Cassia abbreviata is a versatile tree characterized by its sturdy, self-supporting growth form. This plant exhibits a remarkable range in stature, with individual specimens potentially measuring as small as 0.3 meters. However, as the species matures, it typically reaches a significant height of at least 8 meters. In optimal conditions, these trees can continue to climb until they reach a maximum height of 13 meters. This wide variation in size allows the species to adapt effectively to its surrounding environment.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Cassia abbreviata possesses unique chemical properties that significantly influence its physiological effects and potential for drug interactions. Research indicates that the stem bark of this plant contains histamine or a chemically related substance, which is responsible for lowering blood pressure in animal models. Furthermore, phytochemical fingerprinting via UPLC-MS analysis has revealed that the plant is rich in polyphenols. These polyphenolic compounds are believed to be the drivers of the plant's therapeutic properties and may also contribute to its observed inhibition of CYP450 enzymes. Understanding these specific components is essential for assessing the risks of herb-drug interactions when the plant is co-administered with other medications.

Conditions

Cassia abbreviata inhibits the CYP450 enzymes CYP1A2, CYP2C19, and CYP2C9, demonstrating potential for herb-drug interactions. This plant also serves as an effective phytonematicide by suppressing the population densities and reproductive potential of the nematode Meloidogyne incognita. Furthermore, organic fractions of the plant exhibit high in-vitro antimalarial activity against the multi-drug-resistant Plasmodium falciparum; VI/S strain. These diverse biological effects highlight the plant's significant medicinal properties across different therapeutic applications. Combined, these findings underscore the multifaceted pharmacological impact of Cassia abbreviata on enzymatic, parasitic, and protozoan targets.

Preparations

Cassia abbreviata is prepared as extracts which have been tested for their ability to inhibit CYP450 enzymes and HIV-1c replication. This plant is also prepared as aqueous and organic fractions that demonstrate significant in-vitro antimalarial activity against Plasmodium falciparum. Research indicates that Cassia abbreviata is prepared as HSHR, serving as a frequently cited species for managing goat ailments in ethnoveterinary medicine. Additionally, the plant is prepared as acetone extracts that show inhibitory effects against various Gram-positive and Gram-negative bacteria. Finally, Cassia abbreviata is prepared as a crude extract of the stem bark, which has been shown to elicit a dose-dependent fall in blood pressure in anaesthetized rats.

Parts used

Cassia abbreviata is a versatile medicinal plant that contains several biologically active components found in its various parts. Research indicates that the leaves and roots of the species demonstrate significant in-vitro antimalarial activity against Plasmodium falciparum. Additionally, the stem, specifically the stem bark, has been shown to induce a dose-dependent fall in blood pressure in animal models. Beyond these uses, the plant's stem and leaves also contribute to its potential as a phytonematicide for suppressing nematode populations. Together, these findings highlight the therapeutic importance of the different anatomical structures of Cassia abbreviata.